Roles of chronic low-grade inflammation in the development of ectopic fat deposition

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Liu, Lulu ^a   Mei, Mei ^a   Yang, Shumin ^a   Li, Qifu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CELL DIFFERENTIATION; DISEASE SEVERITY; FAT CONTENT; HOMEOSTASIS; INFLAMMATION; KIDNEY; LIPID STORAGE; LIPOLYSIS; LIVER; METABOLIC DISORDER; MOLECULAR MECHANICS; PANCREAS; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW; ANIMAL; HUMAN; LIPID METABOLISM; METABOLISM;

ADIPOSE TISSUE; ANIMALS; HUMANS; INFLAMMATION; LIPID METABOLISM; TRIGLYCERIDES;

EID: 84927171563     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/418185     Document Type: Review

References (51)

1. A. Lettner and M. Roden, "Ectopic fat and insulin resistance, " Current Diabetes Reports, vol. 8, no. 3, pp. 185-191, 2008.
2. I. J. Elenkov, D. G. Iezzoni, A. Daly, A. G. Harris, and G. P. Chrousos, "Cytokine dysregulation, inflammation and wellbeing, " NeuroImmunoModulation, vol. 12, no. 5, pp. 255-269, 2005.
3. J. W. Haukeland, J. K. Damas, Z. Konopski et al. , "Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2, " Journal of Hepatology, vol. 44, no. 6, pp. 1167-1174, 2006.
4. M. M. Smits and E. J. van Geenen, "The clinical significance of pancreatic steatosis, " Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 3, pp. 169-177, 2011.
5. S. H. Park, B. I. Kim, J. W. Yun et al. , "Insulin resistance and C-reactive protein as independent risk factors for nonalcoholic fatty liver disease in non-obese Asian men, " Journal of Gastroenterology and Hepatology, vol. 19, no. 6, pp. 694-698, 2004.
6. G. H. Goossens, "The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance, " Physiology & Behavior, vol. 94, no. 2, pp. 206-218, 2008.
7. M. L. Reitman and O. Gavrilova, "A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes, " International Journal of Obesity & Related Metabolic Disorders, vol. 24, supplement 4, pp. S11-S14, 2000.
8. A. Garg and A. K. Agarwal, "Lipodystrophies: disorders of adipose tissue biology, " Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1791, no. 6, pp. 507-513, 2009.
9. P. Iglesias, P. A. Fidalgo, R. Codoceo, and J. J. Diz, "Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations, " Endocrine Journal, vol. 51, no. 3, pp. 279-286, 2004.
10. K. Sevastianova, J. Sutinen, K. Kannisto, A. Hamsten, M. Ristola, and H. Yki-Jrvinen, "Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapyassociated lipodystrophy, " American Journal of Physiology-Endocrinology and Metabolism, vol. 295, no. 1, pp. E85-E91, 2008.
11. B. Cousin, M. Andr, E. Arnaud, L. Pnicaud, and L. Casteilla, "Reconstitution of lethally irradiated mice by cells isolated from adipose tissue, " Biochemical and Biophysical Research Communications, vol. 301, no. 4, pp. 1016-1022, 2003.
12. R. M. Hagen, S. Rodriguez-Cuenca, and A. Vidal-Puig, "An allostatic control of membrane lipid composition by SREBP1, " FEBS Letters, vol. 584, no. 12, pp. 2689-2698, 2010.
13. B. Gustafson and U. Smith, "Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes, " The Journal of Biological Chemistry, vol. 281, no. 14, pp. 9507-9516, 2006.
14. F. B. Filippin-Monteiro, E. M. de Oliveira, S. Sandri, F. H. Knebel, R. C. Albuquerque, and A. Campa, "Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance, " International Journal of Obesity, vol. 36, no. 8, pp. 1032-1039, 2012.
15. J. Salles, N. Tardif, J.-F. Landrier et al. , "TNFα gene knockout differentially affects lipid deposition in liver and skeletalmuscle of high-fat-diet mice, " The Journal of Nutritional Biochemistry, vol. 23, no. 12, pp. 1685-1693, 2012.
16. M. Lafontan and D. Langin, "Lipolysis and lipidmobilization in human adipose tissue, " Progress in Lipid Research, vol. 48, no. 5, pp. 275-297, 2009.
17. M. J. Watt, A. L. Carey, E. Wolsk-Petersen, F. B. Kraemer, B. K. Pedersen, and M. A. Febbraio, "Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion, " Diabetologia, vol. 48, no. 1, pp. 105-112, 2005.
18. Y. K. Ji, K. Tillison, J. Lee, D. A. Rearick, and C. M. Smas, "The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-α in 3T3-L1 adipocytes and is a target for transactivation by PPARγ, " American Journal of Physiology: Endocrinology and Metabolism, vol. 291, no. 1, pp. E115-E127, 2006.
19. S. Kralisch, J. Klein, U. Lossner et al. , "Isoproterenol, TNFα, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes, "Molecular and Cellular Endocrinology, vol. 240, no. 1-2, pp. 43-49, 2005.
20. X. Yang, X. Zhang, B. L. Heckmann, X. Lu, and J. Liu, "Relative contribution of adipose triglyceride lipase and hormonesensitive lipase to tumor necrosis factor-α (TNF-α)-induced lipolysis in adipocytes, "The Journal of Biological Chemistry, vol. 286, no. 47, pp. 40477-40485, 2011.
21. P. Nguyen, V. Leray, M. Diez et al. , "Liver lipid metabolism, " Journal of Animal Physiology and Animal Nutrition, vol. 92, no. 3, pp. 272-283, 2008.
22. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, "The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343-1351, 2005.
23. D. Greco, A. Kotronen, J. Westerbacka et al. , "Gene expression in human NAFLD, " The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 294, no. 5, pp. G1281-G1287, 2008.
24. ?O. Basr, E. Akbal, S. Kkl et al. , "Increased H-FABP concentrations in nonalcoholic fatty liver disease, " Herz, vol. 38, pp. 417-422, 2013.
25. M. Vida, A. Serrano, M. Romero-Cuevas et al. , "IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation, " Liver International, vol. 33, no. 7, pp. 1019-1028, 2013.
26. M. Mei, L. Zhao, Q. Li et al. , "Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice, " Lipids in Health and Disease, vol. 10, article 110, 2011.
27. L. Yang and D. Chen, "Effects of TNF alpha on the expression of SCAP and triglyceride contents in cultured steatotic hepatocytes, " Chinese Journal ofHepatology, vol. 15, no. 10, pp. 767-770, 2007.
28. X. Zhu, Q. Liu, M. Wang et al. , "Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. , " PLoS one, vol. 6, no. 11, p. e27081, 2011.
29. Y. Yamazaki, I. Usui, Y. Kanatani et al. , "Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice, " American Journal of Physiology: Endocrinology and Metabolism, vol. 297, no. 5, pp. E1179-E1186, 2009.
30. M. Kohjima, M. Enjoji, N. Higuchi et al. , "Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease, " International Journal of Molecular Medicine, vol. 20, no. 3, pp. 351-358, 2007.
31. H. Glosli, O. A. Gudbrandsen, A. J. Mullen et al. , "Downregulated expression of PPARα target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFα, " Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids, vol. 1734, no. 3, pp. 235-246, 2005.
32. A. Purushotham, T. T. Schug, Q. Xu, S. Surapureddi, X. Guo, and X. Li, "Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, " Cell Metabolism, vol. 9, no. 4, pp. 327-338, 2009.
33. F. Hong, S. Radaeva, H. Pan, Z. Tian, R. Veech, and B. Gao, "Interleukin 6 alleviates hepatic steatosis and ischemia/ reperfusion injury in mice with fatty liver disease, " Hepatology, vol. 40, no. 4, pp. 933-941, 2004.
34. G.-S. Chew, S. Myers, A. C. Shu-Chien, and T. S. T. Muhammad, "Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2-and PI3Kinduced STAT1/3 in HepG2 hepatocyte cells, " Molecular and Cellular Biochemistry, vol. 388, no. 1-2, pp. 25-37, 2014.
35. C.-H. Chew, G.-S. Chew, N. Najimudin, and T. S. Tengku-Muhammad, "Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/ enhancer-binding proteins in hepatocytes, " International Journal of Biochemistry and Cell Biology, vol. 39, no. 10, pp. 1975-1986, 2007.
36. V. B. Matthews, T. L. Allen, S. Risis et al. , "Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance, " Diabetologia, vol. 53, no. 11, pp. 2431-2441, 2010.
37. S. Chaikate, T. Harnroongroj, Y. Chantaranipapong et al. , "Creactive protein, interleukin-6, and tumor necrosis factor-α levels in overweight and healthy adults, " SoutheastAsian Journal of TropicalMedicine and PublicHealth, vol. 37, no. 2, pp. 374-381, 2006.
38. S. Prez, P. Aspichueta, B. Ochoa, and Y. Chico, "The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes, " Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids, vol. 1761, no. 2, pp. 160-171, 2006.
39. L. J. C. van Loon and B. H. Goodpaster, "Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state, " Pflugers Archiv European Journal of Physiology, vol. 451, no. 5, pp. 606-616, 2006.
40. M. Li, C. Paran, N. E. Wolins, and J. F. Horowitz, "High muscle lipid content in obesity is not due to enhanced activation of key triglyceride esterification enzymes or the suppression of lipolytic proteins, " The American Journal of Physiology: Endocrinology and Metabolism, vol. 300, no. 4, pp. E699-E707, 2011.
41. L. Al-Khalili, K. Bouzakri, S. Glund, F. Lnnqvist, H. A. Koistinen, and A. Krook, "Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle, " Molecular Endocrinology, vol. 20, no. 12, pp. 3364-3375, 2006.
42. A. G. Holmes, J. L. Mesa, B. A. Neill et al. , "Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARα and UCP2 expression in rats, " Journal of Endocrinology, vol. 198, no. 2, pp. 367-374, 2008.
43. C. R. Bruce and D. J. Dyck, "Cytokine regulation of skeletal muscle fatty acidmetabolism: effect of interleukin-6 and tumor necrosis factor-α, " American Journal of Physiology: Endocrinology and Metabolism, vol. 287, no. 4, pp. E616-E621, 2004.
44. E. W. Petersen, A. L. Carey, M. Sacchetti et al. , "Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro, " American Journal of Physiology-Endocrinology and Metabolism, vol. 288, no. 1, pp. E155-E162, 2005.
45. A. L. Carey, G. R. Steinberg, S. L. Macaulay et al. , "Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPactivated protein kinase, " Diabetes, vol. 55, no. 10, pp. 2688-2697, 2006.
46. K. Q. Wan, L. J. Lei, Z. Lei, Q. Li, C. Y. Xi, and X. Z. Ruan, "Inflammatory cytokines up-regulate FAT/CD36 expression in renal cells loaded by fatty acids, " Chinese Journal of Pathophysiology, vol. 28, pp. 308-313, 2012.
47. Z. E. Xu, Y. Chen, A. Huang et al. , "Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice, " American Journal of Physiology: Renal Physiology, vol. 301, no. 4, pp. F713-F722, 2011.
48. M. A. Guzzardi and P. Iozzo, "Fatty heart, cardiac damage, and inflammation, " The Review of Diabetic Studies, vol. 8, no. 3, pp. 403-417, 2011.
49. I. Zib, A. N. Jacob, I. Lingvay et al. , "Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes, " Journal of Investigative Medicine, vol. 55, no. 5, pp. 230-236, 2007.
50. K. L. Ma, J. Liu, J. Ni et al. , "Inflammatory stress exacerbates the progression of cardiac fibrosis in high-fat-fed apolipoprotein e knockout mice via endothelial-mesenchymal transition, " International Journal of Medical Sciences, vol. 10, no. 4, pp. 420-426, 2013.
51. A. Mathur, M. Marine, D. Lu et al. , "Nonalcoholic fatty pancreas disease, " HPB, vol. 9, no. 4, pp. 312-318, 2007.